At variance to STAT3 mutated patient, analyzing CD16, CD56, CD57 cell markers no specific immunophenotype distinguishing STAT5b mutated from wild type patients was evidenced among CD4+ T-LGL leukemia. This evidence concerns the gene NCAM1 and leukemia.